Literature DB >> 5068247

The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one) in man, miniature swine and rat.

S F Sisenwine, C O Tio, S R Shrader, H W Ruelius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5068247

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  7 in total

1.  Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.

Authors:  M V St-Pierre; D van den Berg; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Identification of oxaxepam and lorazepam glucuronides by chemical ionization mass spectrometry.

Authors:  T T Chang; C F Kuhlman; R T Schillings; S F Sisenwine; C O Tio; H W Ruelius
Journal:  Experientia       Date:  1973-06-15

Review 3.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

4.  Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats.

Authors:  A M Stijnen; I Postel-Westra; M W Langemeijer; A Hoogerkamp; R A Voskuyl; C F van Bezooijen; M Danhof
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Concentration-dependent metabolism of diazepam in mouse liver.

Authors:  M V St-Pierre; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-06

6.  Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure.

Authors:  J Dingemanse; F A Sollie; D D Breimer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

7.  Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?

Authors:  H F Liu; M Vincent-Viry; M M Galteau; R Guéguen; J Magdalou; A Nicolas; P Leroy; G Siest
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.